Samples of different concentrations (0-50 μg/mL) were prepared using dilutions of a 100 μg/mL stock solution, prepared by dissolving
the compounds in dimethyl sulfoxide and adjusting the volume to 100 mL. Under identical conditions, Azithromycin and Fluconazole
were tested as the reference standard drugs for bacteria and fungi respectively. Synthesized compounds were tested for activity against
two Gram-positive bacteria (Bacillus substilis, Staphylococcus aureus), two Gram-negative bacteria (Pseudomonas aeruginosa,
Escherchia coli), and two fungal strains (Candida albicans, Aspergillus niger). Specifications of the microorganisms are given in Table
1. The synthesized series showed excellent to good activity against Gram-negative bacteria (P. aeruginosa and E. coli) and the least
activity against Gram-positive bacteria (S. aureus and B. subtilis). All compounds of the series exhibited excellent to moderate
antifungal activity against Aspergillus niger and Candida albicans. Examination of the antimicrobial data (Table 2) revealed that
against Gram-positive bacteria Staphylococcus aureus, compounds 4a, 4c, and 4j were found to be equipotent to azithromycin.
Compounds 4d-4h and 4k have shown MIC values (1 μg/mL), indicating good antibacterial activity. Against the species Bacillus
subtilis, compound 4f shows more potency than standard azithromycin. The compounds 4d and 4e are equipotent to azithromycin.
Compounds 4a-c and 4g-k show moderate to good activity. Towards E. coli, compounds 4a-4n shows more potency than the standard.
Against Pseudomonas aeruginosa, compounds 4a-4d and 4f-4m shows more activity than standard azithromycin. All compounds show
moderate to minimal activity against fungi Candida Albicans and Aspergillus niger.
The structure–activity relationship study (SAR) indicates that a change in the substituent might also affect the antibacterial activity
of title compounds 4a–4n. Compounds having R=H/Cl appeared to have more potential against Gram-positive bacteria Staphylococcus
aureus, Gram-negative bacteria E. coli and Pseudomonas aeruginosa; and moderate potential against fungal pathogens Candida
albicans and Aspergillus niger. Compounds having R=CH3/OCH3 were found to be more active against Gram-positive Bacillus
subtilis, Gram-negative bacteria Escherichia coli, and Pseudomonas aeruginosa .
4. Conclusion
We have reported a one-pot synthesis of ethyl 2-(4-acetyl-3-methyl-5-(phenylamino)thiophen-2-yl)-2-oxoacetate derivatives 4a-4e,
ethyl 3-(4-acetyl-3-methyl-5-(phenylamino)thiophen-2-yl)-3-oxopropanoate derivatives 4f-4i, and di((4-acetyl-3-methyl-5-
phenylamino)thiophen-2-yl)ketone derivatives 4j-4n from readily available acetyl acetone 1, phenyl isothiocynates 2a-2e, and 2-
chloromethyl derivatives 3a-3c under mild conditions. The reaction is applicable to a wide range of starting materials. All the
synthesized compounds were evaluated for their antibacterial activities against S. aureus, B. subtilis, E. coli, P. aeruginosa, Candida
albicans, and Aspergillus niger microorganisms by the serial dilution method. The synthesized series showed excellent to good activity
against Gram-negative micro-organisms (P. aeruginosa and E. coli) and the least activity against Gram-positive bacteria (S. aureus
and B. subtilis). All compounds of the series exhibited moderate to less antifungal activity against Aspergillus niger and Candida
albicans.
Acknowledgments
The authors are thankful to the Dr. S. B. Jadhav Head, Dept of Pharmaceutical Chemistry, Modern College of Pharmacy Nigdi Pune-
44 & Mr. Dnyaneshwar D. Daware for providing necessary help during this work.
References
[1] A. Dömling, W. Wang, K. Wang, Chemistry and biology of multicomponent reactions, Chem. Rev. 112 (2012) 3083-3135.
[2] A. Dömling, Recent developments in isocyanide based multicomponent reactions in applied chemistry, Chem. Rev. 106 (2006) 17-89.
[3] F.M. Moghaddam, H.Z. Boinee, An efficient and facile one-step synthesis of highly substituted thiophenes, Tetrahedron 60 (2004) 6085-6089.
[4] K.I. Molvi, M. Mansuri, V. Sudarsanam, et al., Synthesis, anti-inflammatory, analgesic and antioxidant activities of some tetrasubstituted thiophenes,
J. Enzyme. Inhib. Med. Chem. 23 (2008) 829-838.
[5] M.K. Parai, G. Panda, V. Chaturvedi, Y.K. Manju, S. Sinha, Thiophene containing triarylmethanes as antitubercular agents, Bioorg. Med. Chem. Let.
18 (2008) 289-292.
[6] W. Wardakhan, O. Abdel-Salam, G. Elmegeed, Screening for antidepressant, sedative and analgesic activities of novel fused thiophene derivatives,
Acta. Pharm. 58 (2008) 1-14.
[7] S. Sharma, F. Athar, M.R. Maurya, A. Azam, Copper(II) complexes with substituted thiosemicarbazones of thiophene-2-carboxaldehyde: synthesis,
characterization and antiamoebic activity against E. histolytica, Eur. J. Med. Chem. 40 (2005) 1414-1419.
[8] O.F. William, Principles of Medicinal Chemistry, 3rd. ed., Lippincott Williams & Wilkins Publication, Philadelphia, 1989.
[9] A.A. Sagardoy, M.J. Gil, R. Villar, et al., Benzo[b]thiophene-6-carboxamide 1,1-dioxides: Inhibitors of human cancer cell growth at nanomolar
concentrations, Bioorg. Med. Chem. 18 (2010) 5701-5707.
[10] A.A. Fadda, E. Abdel-Latif, R.E. El-Mekawy, Synthesis and molluscicidal activity of some new thiophene, thiadiazole and pyrazole derivatives, Eur.
J. Med. Chem. 44 (2009) 1250-1256.
[11] Indian Pharmacopoeia, Microbiological assay of Antibiotics, vol. I, 2007, pp. 45-52.
[12] C.R. Kokare, Pharmaceutical Microbiology and Biotechnology, 3rd. ed., Nirali Prakashan, Pune, 2006, pp. 21.1-21.12.
[13] Ananthanarayan and Paniker, Textbook of Microbiology, 7th. ed., Orient Blackswan, 2005, pp. 628-630.
[14] Y.J. Huang, A. Dömling, The Gewald multicomponent reaction, Mol. Divers. 15 (2011) 3-33.
Page 4 of 6